Treatment Succeeds for Secondary Cancer After CAR-T, Case Report Shows

(MedPage Today) — Researchers reported that they successfully used targeted therapy to treat a rare and aggressive T-cell lymphoma that developed after chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma.
A 51-year-old patient…